MU
Micron Technology, Inc.
stock NASDAQ

Any good data out to support that tariff is affecting the economy?
Looking at FDX, and NKE, they seem to think tariff affect is going be minor and NKE did they say the worst is behind them in their earnings call. So, is the assumption here that Trump going TACO? and the consumer will be able to absord tariff increase? Unemployment data comes out Thursday since Friday market is closed, but going based off weekly unemployment claims look like unemployment should continue to remain stable. Also, MU earnings shows strong demand for semi, and TSMC monthly sales retirates there is more demand than supply for semi.

**Stocks to Buy Now:** APPS, CAMT, CAT, CMP, COMM, EVEX, HLF, HOVR, IDAI, MBLY, NVDA, PERF, VSAT
**Buys triggered 6/26:** (My apologies I was not able to post an update)
AMAT, AMD, RDDT
**Buys triggered 6/23** (as posted in chat reply):
CRSP, DDOG, DNA,GSAT, RFIL, VTSI, ASPS, KRMD, OUST, SMCI, TMRC, TTEC
**Stocks to sell now:**  INVA, MITK, PZZA, SMR,
**Recent Sells:**  AMPX, HOVR, LAES, OPRT, RCAT, SERV, SLDP, SPWH, VRAR
**Close to Buy Triggers:**  AAOI, ANET, ASLE, ATKR, AVNW, BASE, BLBD, BLDP, BOOM, BYON, CHGG, CORT, CRCT, DATS, DH, DOCS, DTI, EL, ELF, EVTL, FCUV, GCT, GTM, IPGP, IRDM, ISPO, JMIA, KOP, LDOS, LIDR, MCHP, MEI, MX, NE, NUE, NUS, NVA, OCGN, PATH, POWL, QRVO, QUBT, RDW, SBLK, SCI, SEDG, SERV, SGA, SHLS, SLDP, SKYW, SMSI, SNAP, STM, TDOC, TDW, TEX, TITN, TNXP, TTEC, TXG, UGP, UI, ULBI, URG, VALE, VRNS
**Current model owned stocks (stop sell price):**
**Updated (stop sell) orders calculated from technical analysis model output.**
AEVA (26.59), ALAB (84.14), AMD (124.10), AVAV (172.78), BB (3.56), CELH (36.53), CPNG (27.70), CRS (215.72), CRSP (43.14), CVAC (5.10), DAVE (224.68), DHX (2.17), DLTR (83.85), DNA (8.67), EBAY (71.99), EYE (19.53), HOVR (1.66), IDN (4.73), IE (7.55), INTZ (1.91), INVA (18.81), INTZ (1.95), INVZ (1.11), IONQ (37.35), LASR (16.70), LHX (226.93), LINC (19.55), LPTH (2.45), MITK (15.23), MOS (31.46), MP (32.65), MTW (9.78), MTZ (155.32), MU (111.02), MVST (3.38), NFLX (1103.46), NOW (955.95), NTR (54.54), OKLO (52.21), OPRX (11.42), PLAY (27.51), PLTR (125.09), PODD (292.61), PWR (313.14), RDDT (128.23), RFIL (4.63), RKLB (31.19), ROK (308.31), RPID (3.22), SAGE (7.07), SNOW (195.55), SNT (3.23), SNT (3.23), SSP (2.30), SYM (27.19), TDUP (6.34), TLN (230.72), TSSI (22.70), TWLO (103.25), ULTA (459.60), VRT (106.29), VUZI (2.45), W (42.69), WWD (198.54)
Quantity of current Holdings:      69 stocks (70% equity)
New Sells                                             -4
New Buys                                            13
New Quantity of Stocks:                 74
**Market Timing Model Status Update**    **Green.**  For accounts that can only invest in equity index funds, recommended position is 100% equity index.
Happy Investing,
Ludicrous Returns

Hey guys,
I'll be sharing a newsletter from a flow I created daily for free if anyone wants to read it; it compiles information from various sources (news, newsletters, reddit, twitter etc, creates some underlying reports etc). It's just a project of mine which I'm not planning to commercialize and simply want to see if there is any feedback :)
The answer is theoretically customized to cater to a high risk, knowledgable investor.

Alright, let's cut to the chase. Here's the lay of the land for today, June 30, 2025. The market is running a two-speed playbook, and if you're not on the right side of it, you're getting left behind.
\### Today's Market Briefing: The Great Divergence Accelerates
Bottom Line Up Front: The market is a tale of two cities. 🏙️ On one street, AI and tech are throwing a block party, fueled by massive deals and relentless momentum. On the other, the macro storm clouds are gathering, with giants like BlackRock sounding the alarm. Our AI Signal's "Great Divergence" theme isn't just a forecast; it's happening in real-time today. The play is to ride the tech wave while keeping a close eye on the macro cracks.
\---
\### 📈 What's Driving the Action Today
The news flow is perfectly illustrating this split personality. Here's what's moving the needle right now:
\#### 1. The AI Engine Roars Louder 🚀
The AI momentum is not slowing down; it's finding new ways to accelerate.
Palantir (PLTR) & Accenture (ACN) Team Up: Palantir shares jumped \~5% today on a major strategic partnership with Accenture Federal Services. According to the announcement, Accenture's massive Data & AI team will train on Palantir's platform to supercharge government deployments. This is a critical development, moving beyond hype to real-world, large-scale enterprise adoption. It's a textbook example of the AI application layer creating value.
Source: Palantir Stock Jumps on Accenture Federal AI Partnership:
https://finance.yahoo.com/news/palantir-stock-jumps-accenture-federal-163425936.html
Semiconductor Strength Continues: While the news is from late last week, the sentiment is carrying over. Nvidia (NVDA) continues to flirt with a $4 trillion market cap (https://finance.yahoo.com/news/nvidia-breakout-puts-4-trillion-100304547.html), and Micron's (MU) stellar earnings, driven by AI data center demand, are lifting the entire memory sector. The foundation of the AI trade remains rock-solid.
\#### 2. Fintech Disrupts TradFi 🔗
The lines between traditional finance and crypto are blurring, creating explosive opportunities.
Robinhood (HOOD) Goes Global: Robinhood is surging today after launching tokenized trading for over 200 U.S. stocks and ETFs for its European users. As detailed in the news from [Investing.com](https://www.investing.com/news/stock-market-news/robinhood-launches-tokens-allowing-eu-users-to-trade-in-us-stocks-4117441), this move, in partnership with Arbitrum, allows 24/7, commission-free trading. This is a direct shot across the bow of traditional exchanges and a massive validation for blockchain-based capital markets. HOOD is trending heavily on social media, and for good reason.
\#### 3. Big Pharma on the Hunt 💊
The Healthcare sector is proving its "new defensive" status with aggressive M&A.
AbbVie (ABBV) Buys Capstan: AbbVie announced it's acquiring cell therapy developer Capstan Therapeutics for up to $2.1 billion. This is a strategic move to bolster its immunology pipeline as its blockbuster drug, Humira, faces patent cliffs. This shows that cash-rich pharma giants are actively buying innovation, creating value and putting a floor under the sector.
Source: AbbVie to buy Capstan for up to $2.1 billion in immunology push (https://www.investing.com/news/stock-market-news/abbvie-to-buy-capstan-therapeutics-for-up-to-21-billion-4116986)
\---
\### 💣 The Macro Headwinds Are Building
While the tech party rages, don't ignore the warning sirens. The macro picture is getting darker, and the institutional players are taking notice.
BlackRock Sounds the Alarm on US Debt: In a high-importance report today, BlackRock (BLK) explicitly stated that surging U.S. government debt is the "greatest risk to US market standing." They warn that the debt could sap appetite for U.S. assets and are advising clients to diversify. When the world's largest asset manager issues a warning this stark, you listen. This is the institutional validation of the fears we've been tracking.
Source: Rising government debt poses greatest risk to US market standing, says BlackRock (https://www.investing.com/news/stock-market-news/abbvie-to-buy-capstan-therapeutics-for-up-to-21-billion-4116986)
Fed & Political Pressure Cooker: The fallout from Fed Chair Powell's testimony last week continues to simmer. The Fed is walking a tightrope, trying to be "data-dependent" while facing immense political pressure to cut rates. This uncertainty is a key source of volatility. The Fed's move to ease capital requirements for big banks, as reported by CNBC, shows they are trying to keep the financial plumbing working, but the underlying stress is evident.
Retail Jitters: On the social media front, there's a tangible sense of unease. Reddit discussions point to a "strange calm" (https://thehill.com/homenews/senate/5375991-gop-tax-bill-health-cuts/) and investor complacency, while also highlighting risks from the GOP tax bill, a weak housing market, and the looming July 9 tariff deadline.
In short, the market is giving us a clear signal: The momentum is with AI-centric tech and innovative healthcare. The risk is in the broad economy and cyclical sectors exposed to policy blunders and a weakening consumer. Trade accordingly.

I just realized that AMD's and MU's recent charts looks fairly similar. Both indicating some indecision and a possible short-term top.
While MU's news is out, AMD is still trading on hope until we hit earnings. I also think the upside target for AMD is about $180.

Stocks to watch: $NRG $PLTR $NFLX $MU $BGM $UBER $CRWD

Stocks to watch: $NRG $PLTR $NFLX $MU $BGM $UBER $CRWD

Do you think MU will get close to it's 155 target price ?

My MU calls are waiting for the push up post a good ER…dunno how long the waits gonna be - have 150c for September

Stocks made a swift and historic comeback from the market's April bottom, with the S&P 500 (\^GSPC) closing at a record high on Friday.
Now, as the first half of 2025 draws to a close, overarching risks are all but removed. From tariff-driven inflation pressures to conflicting economic signals and murky data, what lies ahead is anything but straightforward.
"We are going to see an inflation reacceleration that will be tariff-induced," EY chief economist Greg Daco told Yahoo Finance on Friday. "There's more pressure to come into the economy \[and that will lead to\] income erosion and a consumer spending slowdown. That is really the picture that we should expect in the second half of this year."
Stocks like AVGO, MU, BGM, HIMS, NKE, and AVAV could see shifting interest amid evolving inflation and consumer trends.

source: [investing.com](http://investing.com)
**Nike (NYSE:NKE)**
Nike shares surged Friday after the company posted its latest quarterly earnings, topping consensus expectations for profit and revenue.
The sportswear giant’s CEO, Elliott Hill, stated that the company is “turning the page and the next step is aligning our teams to lead with sport. through what we are calling the sport offense.”
Reacting to the report, HSBC upgraded Nike to Buy from Hold, raising its target for the stock to $80 from $60 per share.
“We think there is more than tangible evidence that Nike has a path to see its sales rebound in the not-too-distant future, and its margins to be repaired, and this despite an unfavourable tariff headwind which the group believes could weigh for 75bps on gross margin in FY May 2026,” the bank wrote in a note to clients.
Nike shares are on course to gain more than 20% over the last week.
**Nvidia (NASDAQ:NVDA)**
Nvidia shares hit a new all-time high for the first time since January this week. The stock has risen by more than 9% in the last week.
Furthermore, the company is nearing a market capitalization $4 trillion.
In a note to clients Friday, Wedbush analysts said “the race to $4 trillion market cap has begun with Microsoft (NASDAQ:MSFT) and Nvidia nearing,” adding both companies are “foundational pieces of building on the biggest tech trend we have seen in our 25 years covering tech stocks.”
**Hims & Hers Health**
HIMS shares tumbled more than 34% on Monday, with the stock down around 22% in the last week.
Monday’s plunge came after Novo Nordisk (NYSE:NVO) terminated a short-lived deal to sell its Wegovy weight-loss drug through Hims & Hers Health.
Novo said it ended the collaboration due to “Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy® that put patient safety at risk.”
**AeroVironment (NASDAQ:AVAV)**
AVAV surged this week, gaining around 45% after reporting quarterly earnings that impressed investors and analysts alike. The company beat consensus earnings and revenue expectations.
“4Q25 results were better-than-anticipated,” said analysts at Stifel. “We are positive on management’s plans to accelerate CapEx spending as we expect investors to begin to look more favorably on organic growth investments in new defense tech.”
The firm reiterated its Buy rating and $240 target price on AVAV shares.
**Core Scientific**
Core Scientific stock also surged this week, gaining more than 33% on Thursday after reports emerged that CoreWeave, a provider of artificial intelligence cloud infrastructure, is once again in advanced talks to acquire the bitcoin mining and hosting company.
According to a report by The Wall Street Journal, the two firms could finalize a transaction in the coming weeks, provided negotiations proceed smoothly.
Following the reports, Jefferies analysts stated in a note: “In our view, the combination of the two makes strategic sense for CRWV to vertically integrate its infrastructure, reduce opex, and use the CORZ platform to grow its DC development pipeline.
“We estimate a potential takeout value range of $16-$23."
Core Scientific shares are up approximately 40% in the last week.
**Circle**
Last week, Circle made the list as its stock gained significant momentum following its market debut earlier this month.
The company’s shares were also boosted last week by news that the U.S. Senate had approved a milestone stablecoin bill, which could bring regulatory clarity to the cryptocurrency sector.
However, the stock has since pulled back, down around 21% in the last week.
AVAV, MSFT, BGM, MU, HIMS, and NKE may attract attention as investors rotate across AI infrastructure, consumer recovery, and emerging tech trends.
In a note to clients this week, Compass Point initiated coverage on CRCL with a Neutral rating and a $205 price target. The firm pointed to both its leadership in regulated stablecoins and challenges in distribution as reasons for its cautious rating.
Analysts noted that stablecoins could disrupt traditional finance by disintermediating banks and payment networks.

U.S. stock futures rose Sunday evening after major Wall Street indexes saw weekly gains with the S&P 500 and Nasdaq hitting record closing highs, while President Donald Trump’s tax cut bill advanced in the Senate.
S&P 500 Futures inched 0.3% higher to 6,241.75 points, while Nasdaq 100 Futures rose 0.4% to 22,841.75 points by 20:45 ET (00:45 GMT). Dow Jones Futures were trading 0.5% higher at 44,342.0 points.
Trump’s tax cut bill advances in Senate
The Senate on Saturday narrowly approved a 51–49 procedural vote to open debate on President Donald Trump’s comprehensive “One Big Beautiful Bill,” combining tax cuts, domestic spending changes, and border security provisions
The bill’s advancement sets up a high-stakes week of legislative maneuvering, beginning with up to 20 hours of debate.
According to a Congressional Budget Office (CBO) estimate, the Senate’s version of the bill would add approximately $3.3 trillion to the federal deficit over the next decade.
Despite Senate Republicans aiming to wrap up the process before the July 4 holiday, the bill faces further hurdles in the House, where members have raised objections to the deficit impact and rushed timeline.
The Republican-controlled U.S. House of Representatives passed its version of the bill last month.
S&P 500, Nasdaq hit record closing highs
In the regular trading session on Friday, the S&P 500 rose 0.5% to an all-time closing high. The NASDAQ Composite also closed 0.5% higher, reaching its record peak.
The Dow Jones Industrial Average jumped 1%, and was just short of nearly 3% to scale a record closing high.
Markets advanced last week on rising expectations of a Federal Reserve rate cut, spurred by weaker-than-expected inflation data. Sentiment was further lifted by hopes that trade agreements could be reached before President Trump’s July 9 deadline.
Investors also reacted positively to the Israel-Iran ceasefire brokered by Trump.
AMD, BGM, MU, FSLY, and CRM could see renewed interest as expectations for rate cuts and fiscal stimulus support both large and mid-cap growth names.
Fed Chair Jerome Powell emphasized caution last week, stating that tariff-driven inflation increases are expected in upcoming data. Still, markets have shifted expectations toward cuts, with futures now pricing in two reductions later this year.

Entered MU and PLTR short put spreads (before PLTR tanked) on Friday. If MU or SMCI dips anymore, looking at naked calls.

MU to the moon plz

MU & WDC 🦖🍆

MU is interesting, healthy PE. Earnings were decent, increased demand in AI chips though it was already priced in throughout the months leading up to earnings. That’s why we saw a decline after an earnings beat rather than an increase. Think of NVDA the same way, their ultra high evaluation is going to lead to ultra high earnings beats pre priced in and if there are turbulence even if they beat those earnings… it’s going to drop.
You know how startups will get those ultra high evaluations at first when they aren’t profitable because they seem to think they will be able to crush them in the future and having those ultra high evaluations leads to the company being forced to perform better and better each quarter and turn further profit.
Essentially the same thing here but not as risky as a start up. More and more money will be pumped in to NVDA but as soon as they start getting competitors or losing market share… just like 90% of silicone valley start ups… they will drop…
You might think I’m crazy comparing the most valuable company to a startup but it’s just the numbers aspect of it rather than the fundamental aspect. Ultra high evaluations means ultra high growth big earnings beats consistently. If for whatever reason that is not maintained… then big drops happen… and it is unsustainable so at some point in time their will be competition, and their will be growth from other chip manufacturers.

Hi expired options great premium week in week out! As we approach the second half of this year, I averaged around 1k per week, after accounting for the realised loss for selling CC below cost basis which includes MU. The amount here is not the point but rather I was thinking about the lessons learnt during the period. The CC was sold during the Trump tariff period and how the various stocks have run up make it very tough to roll to my cost basis (also because the strike price was a tad too low of cos)
On this note just wondering how do you deal with the depressed prices in the last few months before the run-up? Do you keep very strictly to the principles of not selling CC below cost basis?

My thinking is actually;
Ex US will underperform as along as there's an administration that is hellbent on devaluing the dollar. Outperforming when you have FX currency headwinds is herculean.
EM generally does better when the USD is weak given a lot of their interest rates are US denominated. Also it frees up fiscal expansion for their nations.
Japan and Korea looks committed to increasing the corporate governance of their major bourses. In no normal world should SK Hynix trade at a discount to MU if the chaebol discount is removed.
China (mostly the Hong Kong exchange) is inflecting because the central government has gone 180 degrees from trying to kill privates and favour SOEs to now directing SOEs to lend to privates for share buybacks. Xi lost his battle on the private sector and he is eating crow right now.
Apart from SAAB and Airbus I don't actually have EU. Have issues with their culture and love for red tape.

Balls deep on MU at $65